Fennec Pharmaceuticals (FENC) Earnings Date, Estimates & Call Transcripts $8.20 -0.11 (-1.32%) Closing price 04:00 PM EasternExtended Trading$8.20 +0.01 (+0.06%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Fennec Pharmaceuticals Earnings Summary Fennec Pharmaceuticals released Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.04, which topped analysts' consensus estimates of -$0.12 by $0.08. Quarterly revenue was reported to be $8.51 million, above analyst estimates of $8.18 million. With a trailing EPS of -$0.51, Fennec Pharmaceuticals' earnings are expected to decrease next year, from ($0.11) to ($0.15) per share. Upcoming Q2 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 13) -$0.12 Actual EPS (May. 13) -$0.04 Beat By $0.08 Actual Revenue (May. 13) $8.51MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)FENC Upcoming EarningsFennec Pharmaceuticals' next earnings date is estimated for Tuesday, August 12, 2025, based on past reporting schedules. Powered by Get Fennec Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fennec Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataFENC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FENC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Fennec Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.13$0.05-$0.06Q2 20253-$0.07$0.55$0.14Q3 20253-$0.04$1.27$0.54Q4 20253$0.01$2.56$0.89 FY 2025 12 -$0.23 $4.43 $1.52 Q1 20262$0.06$0.15$0.11Q2 20262$0.15$0.23$0.19Q3 20262$0.19$0.30$0.25Q4 20262$0.26$0.36$0.31 Fennec Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/13/2025Q1 2025-$0.12-$0.04+$0.08-$0.04$8.18M$8.51M11/7/2024Q3 2024-$0.13-$0.21 -$0.08-$0.21$9.13M$6.97M8/13/2024Q2 2024$0.06-$0.20 -$0.26-$0.20$13.67M$7.26M5/14/2024Q1 2024$0.49$0.41 -$0.08$0.41$10.46M$25.38M3/21/2024Q4 2023$0.02-$0.10 -$0.12-$0.10$9.47M$9.74M11/6/2023Q3 2023-$0.11-$0.07+$0.04-$0.07$5.22M$6.52M8/3/2023Q2 2023-$0.18-$0.21 -$0.03-$0.21$4.01M$3.33M Fennec Pharmaceuticals Earnings - Frequently Asked Questions When is Fennec Pharmaceuticals's earnings date? Fennec Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on FENC's earnings history. Did Fennec Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Fennec Pharmaceuticals (NASDAQ:FENC) reported ($0.04) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.08. Learn more on analysts' earnings estimate vs. FENC's actual earnings. How can I listen to Fennec Pharmaceuticals's earnings conference call? The conference call for Fennec Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Fennec Pharmaceuticals's conference call transcript? The conference call transcript for Fennec Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded annual revenue of $30.91 million. How much profit does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded net income of -$16.05 million. FENC has generated -$0.51 earnings per share over the last four quarters. What is Fennec Pharmaceuticals's EPS forecast for next year? Fennec Pharmaceuticals's earnings are expected to decrease from ($0.11) per share to ($0.15) per share in the next year. More Earnings Resources from MarketBeat Related Companies LENZ Therapeutics Earnings Date Replimune Group Earnings Date Vir Biotechnology Earnings Date Iovance Biotherapeutics Earnings Date Immatics Earnings Date Anavex Life Sciences Earnings Date Sana Biotechnology Earnings Date Autolus Therapeutics Earnings Date Taysha Gene Therapies Earnings Date Relay Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:FENC) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FENC Stock Free FENC Stock Alerts